119 related articles for article (PubMed ID: 31047842)
1. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells.
Akula SM; Candido S; Libra M; Abrams SL; Steelman LS; Lertpiriyapong K; Ramazzotti G; Ratti S; Follo MY; Martelli AM; Murata RM; Rosalen PL; Bueno-Silva B; Matias de Alencar S; Montalto G; Cervello M; Gizak A; Rakus D; Mao W; Lin HL; Lombardi P; McCubrey JA
Adv Biol Regul; 2019 Aug; 73():100633. PubMed ID: 31047842
[TBL] [Abstract][Full Text] [Related]
2. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells.
Abrams SL; Follo MY; Steelman LS; Lertpiriyapong K; Cocco L; Ratti S; Martelli AM; Candido S; Libra M; Murata RM; Rosalen PL; Montalto G; Cervello M; Gizak A; Rakus D; Mao W; Lombardi P; McCubrey JA
Adv Biol Regul; 2019 Jan; 71():172-182. PubMed ID: 30361003
[TBL] [Abstract][Full Text] [Related]
3. Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53.
Abrams SL; Akula SM; Steelman LS; Follo ML; Cocco L; Ratti S; Martelli AM; Libra M; Falzone L; Candido S; Montalto G; Cervello M; Lombardi P; McCubrey JA
Adv Biol Regul; 2022 Jan; 83():100840. PubMed ID: 34866036
[TBL] [Abstract][Full Text] [Related]
4. APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.
McCubrey JA; Abrams SL; Steelman LS; Cocco L; Ratti S; Martelli AM; Lombardi P; Gizak A; Duda P
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204775
[TBL] [Abstract][Full Text] [Related]
5. GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Abrams SL; Akula SM; Meher AK; Steelman LS; Gizak A; Duda P; Rakus D; Martelli AM; Ratti S; Cocco L; Montalto G; Cervello M; Ruvolo P; Libra M; Falzone L; Candido S; McCubrey JA
Cells; 2021 Apr; 10(4):. PubMed ID: 33917370
[TBL] [Abstract][Full Text] [Related]
6. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
[TBL] [Abstract][Full Text] [Related]
7. Metformin influences drug sensitivity in pancreatic cancer cells.
Candido S; Abrams SL; Steelman L; Lertpiriyapong K; Martelli AM; Cocco L; Ratti S; Follo MY; Murata RM; Rosalen PL; Lombardi P; Montalto G; Cervello M; Gizak A; Rakus D; Suh PG; Libra M; McCubrey JA
Adv Biol Regul; 2018 May; 68():13-30. PubMed ID: 29482945
[TBL] [Abstract][Full Text] [Related]
8. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals.
Abrams SL; Lertpiriyapong K; Yang LV; Martelli AM; Cocco L; Ratti S; Falasca M; Murata RM; Rosalen PL; Lombardi P; Libra M; Candido S; Montalto G; Cervello M; Steelman LS; McCubrey JA
Adv Biol Regul; 2018 Aug; 69():16-34. PubMed ID: 29980405
[TBL] [Abstract][Full Text] [Related]
9. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals.
Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Martelli AM; Cocco L; Ratti S; Follo MY; Murata RM; Rosalen PL; Bueno-Silva B; de Alencar SM; Lombardi P; Mao W; Montalto G; Cervello M; Rakus D; Gizak A; Lin HL; Libra M; Akula SM; McCubrey JA
Adv Biol Regul; 2019 May; 72():22-40. PubMed ID: 30898612
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53.
Abrams SL; Akula SM; Martelli AM; Cocco L; Ratti S; Libra M; Candido S; Montalto G; Cervello M; Gizak A; Rakus D; Steelman LS; McCubrey JA
Adv Biol Regul; 2021 Jan; 79():100780. PubMed ID: 33451973
[TBL] [Abstract][Full Text] [Related]
11. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells.
Akula SM; Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Cocco L; Ramazzotti G; Ratti S; Follo MY; Martelli AM; Murata RM; Rosalen PL; Bueno-Silva B; Matias de Alencar S; Falasca M; Montalto G; Cervello M; Notarbartolo M; Gizak A; Rakus D; Libra M; McCubrey JA
Adv Biol Regul; 2020 Jan; 75():100672. PubMed ID: 31685431
[TBL] [Abstract][Full Text] [Related]
12. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
Turner N; Li JY; Gosby A; To SW; Cheng Z; Miyoshi H; Taketo MM; Cooney GJ; Kraegen EW; James DE; Hu LH; Li J; Ye JM
Diabetes; 2008 May; 57(5):1414-8. PubMed ID: 18285556
[TBL] [Abstract][Full Text] [Related]
13. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1.
Zheng F; Wu J; Tang Q; Xiao Q; Wu W; Hann SS
J Cell Mol Med; 2018 Jan; 22(1):600-612. PubMed ID: 28840963
[TBL] [Abstract][Full Text] [Related]
14. Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
Zhou G; Yu J; Wang A; Liu SH; Sinnett-Smith J; Wu J; Sanchez R; Nemunaitis J; Ricordi C; Rozengurt E; Brunicardi FC
Curr Mol Med; 2016; 16(1):83-90. PubMed ID: 26695692
[TBL] [Abstract][Full Text] [Related]
15. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
[TBL] [Abstract][Full Text] [Related]
16. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
[TBL] [Abstract][Full Text] [Related]
17. Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase.
Li J; Pan Y; Kan M; Xiao X; Wang Y; Guan F; Zhang X; Chen L
Life Sci; 2014 Mar; 98(1):24-30. PubMed ID: 24412384
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy and metformin in pancreatic adenocarcinoma and neuroendocrine tumors.
Burney S; Khawaja KI; Saif MW; Masud F
JOP; 2014 Jul; 15(4):313-6. PubMed ID: 25076330
[TBL] [Abstract][Full Text] [Related]
19. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
20. Berberine attenuates arthritis in adjuvant-induced arthritic rats associated with regulating polarization of macrophages through AMPK/NF-кB pathway.
Zhou J; Yu Y; Yang X; Wang Y; Song Y; Wang Q; Chen Z; Zong S; Fan M; Meng X; Xie C; Zhou F; Liu H; Wei F
Eur J Pharmacol; 2019 Jun; 852():179-188. PubMed ID: 30796904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
